Clinical Trial Update: A Study of ASP8302 in Participants With Underactive Bladder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of ASP8302 for underactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Underactive Bladder

Drugs mentioned

• ASP8302

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Underactive Bladder | Phase 2 | Status: COMPLETED